Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy
The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients
Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort
Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
High frequency of poor locomotor performance in HIV-infected patients
Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing
Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test
CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995–2009
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings
Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda
Scaling-up antiretroviral treatment in resource-poor countries: prioritization and choices
Age-gaps in sexual partnerships: seeing beyond ‘sugar daddies’
The contribution of HIV-discordant relationships to new HIV infections in Rakai, Uganda
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort
High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Authors' reply to correspondence by Le and Farrar
Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?
Do nevirapine and efavirenz affect vitamin D homeostasis similarly?
Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?
Lenalidomide in treating AIDS-related Kaposi's sarcoma
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study: Erratum